Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Alzheimer's
Alzheimer's
Page 5 of 8
Health
Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By
Blockchain Reporter
June 9, 2021
Health
FDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By
Editorial Team
June 7, 2021
Health
President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By
Editorial Team
May 25, 2021
Newsletters
A week about Alzheimer’s drug development
By
Senior Editor
March 18, 2021
Newsletters
Biogen is doubling down on Alzheimer’s with a massive gene therapy deal
By
Market Analyst
February 28, 2020
Newsletters
The Broader Implications of Biogen’s Divisive Alzheimer’s Drug
By
Industry Analyst
December 5, 2019
Newsletters
Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet
By
News Correspondent
December 2, 2019
Newsletters
Bill Gates Commits $10 Million More for Alzheimer’s Research to ‘Part the Cloud’
By
Editorial Team
November 5, 2019
Newsletters
Let’s Talk About Biogen’s Stunning Alzheimer’s Drug Reversal: Brainstorm Health
By
Industry Analyst
October 23, 2019
Health
Roche Reports Another Failure in Big Pharma’s Search for Alzheimer’s Treatment
By
Digital Assets Editor
January 30, 2019
Health
A New Blood Test Could Detect Alzheimers 10 Years Earlier
By
Digital Assets Editor
January 21, 2019
Magazine
The Power of a Joint Venture
By
Senior Editor
January 18, 2019
Could This Radical New Approach to Alzheimer’s Lead to a Breakthrough?
By
Industry Analyst
January 18, 2019
Magazine
Alzheimer’s: A Trail of Disappointment for Big Pharma
By
Tech Reporter
January 18, 2019
Health
Is an Alzheimer’s Vaccine Possible? This Woman Thinks So
By
Investment Desk
October 3, 2018
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Industry Analyst
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Trading Desk
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Trading Desk